111Category: | Pharmaceuticals and Biochemicals |
|
|
CAS NO: | 42200-33-9 | ||
EC NO: | 255-706-3 | ||
Molecular Formula: | C17H27NO4 | ||
Molecular Weight: | 309.4006 | ||
Specification: | |||
InChI: | InChI=1/C17H27NO4/c1-17(2,3)18-9-12(19)10-22-16-6-4-5-11-7-14(20)15(21)8-13(11)16/h4-6,12,14-15,18-21H,7-10H2,1-3H3/t12?,14-,15+/m1/s1 | ||
Product description: Nadolol is a hydrophilic, non-selective beta-blocker. It inhibits response to adrenergic stimulation by competitively blocking beta-1 receptors within the myocardium and beta-2 receptors within bronchial and vascular smooth muscle. Beta-1 receptor |
|||
Synonyms: | Nadolol [USAN:INN:BAN:JAN];Nadolol;Corzide;(2R,3S)-5-(3-(tert-Butylamino)-2-hydroxypropoxy)-1,2,3,4-tetrahydronaphthalene-2,3-diol;1-(tert-Butylamino)-3-((5,6,7,8-tetrahydro-cis-6,7-dihydroxy-1-naphthyl)oxy)-2-propanol;2,3-cis-1,2,3,4-Tetrahydro-5-((2-hydroxy-3-tert-butylamino)propoxy)-2,3-naphthalenediol;5-(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy)-1,2,3,4-tetrahydro-2,3-naphthalenediol;Anabet;CCRIS 1048;Corgard;HSDB 6532;Nadololum;Nadololum [INN-Latin];SQ 11725;Solgol;UNII-FEN504330V;2,3-Naphthalenediol, 5-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-1,2,3,4-tetrahydro-, cis-;5-[3-(tert-butylamino)-2-hydroxypropoxy]-1,2,3,4-tetrahydronaphthalene-2,3-diol; | ||
Molecular Structure: |